Followers | 19 |
Posts | 2094 |
Boards Moderated | 0 |
Alias Born | 06/12/2017 |
Wednesday, June 03, 2020 12:59:33 PM
Recent NBY News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/13/2024 10:15:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/12/2024 09:52:18 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/12/2024 11:01:30 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/08/2024 10:31:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:13:00 PM
- NovaBay Pharmaceuticals Reports Third Quarter 2024 Financial Results • Business Wire • 11/07/2024 09:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/06/2024 09:58:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:46:28 PM
- NovaBay Pharmaceuticals Accepts Revised Offer from PRN Physician Recommended Nutriceuticals, LLC and Enters into an Amendment to the Asset Purchase Agreement to Increase Purchase Price • Business Wire • 11/06/2024 09:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/29/2024 12:19:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 12:15:10 PM
- NovaBay Pharmaceuticals Board Determines Unsolicited Offer is Superior to Asset Purchase Agreement with PRN Physician Recommended Nutriceuticals, LLC • Business Wire • 10/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:27:16 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 10/16/2024 08:19:35 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 09/25/2024 09:17:41 PM
- Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm • PR Newswire (US) • 09/23/2024 01:27:00 PM
- Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals • PR Newswire (US) • 09/20/2024 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/20/2024 12:08:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:08:15 PM
- NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets • Business Wire • 09/20/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:11:02 PM
- NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results • Business Wire • 08/13/2024 08:05:00 PM
- NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024 • Business Wire • 08/01/2024 10:50:00 AM
- NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales • Business Wire • 07/30/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 08:25:15 PM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM